Andrea Baragetti
Overview
Explore the profile of Andrea Baragetti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
64
Citations
1041
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Baragetti A, Alieva A, Grigore L, Pellegatta F, Lupi A, Scrimali C, et al.
Eur Heart J
. 2025 Feb;
PMID: 39928422
Background And Aims: Identification of individuals affected by familial hypercholesterolaemia (FH) is suboptimal when genetic tests are unavailable. Relying only on low-density lipoprotein cholesterol (LDL-C) is challenging as it may...
2.
Albiero M, Baragetti A
Trends Pharmacol Sci
. 2025 Jan;
46(2):102-116.
PMID: 39855946
Current therapies for diabetes and atherosclerotic cardiovascular diseases (ACVDs) mainly target metabolic risk factors, but often fall short in addressing systemic inflammation, a key driver of disease onset and progression....
3.
Trezzi S, Scaccabarozzi G, Nossa R, Piazza C, Bianchi A, Rosi E, et al.
Clin Nutr ESPEN
. 2024 Dec;
65():408-417.
PMID: 39710171
Background & Aims: Considerable interest has been recently given to the potential role of the gut-brain axis (GBA) -a two-way communication network between the gut microbiota and the central nervous...
4.
Svecla M, Moregola A, Da Dalt L, Nour J, Baragetti A, Uboldi P, et al.
Cardiovasc Diabetol
. 2024 Nov;
23(1):428.
PMID: 39616371
The asialoglycoprotein receptor 1 (ASGR1), a multivalent carbohydrate-binding receptor that primarily is responsible for recognizing and eliminating circulating glycoproteins with exposed galactose (Gal) or N-acetylgalactosamine (GalNAc) as terminal glycan residues,...
5.
Parolini A, Da Dalt L, Norata G, Baragetti A
Curr Opin Clin Nutr Metab Care
. 2024 Jul;
27(5):434-442.
PMID: 39083430
Purpose Of Review: Contemporary guidelines for the prevention of cardio-metabolic diseases focus on the control of dietary fat intake, because of their adverse metabolic effects. Moreover, fats alter innate immune...
6.
Dinu M, Sofi F, Lotti S, Colombini B, Mattioli A, Catapano A, et al.
Eur J Prev Cardiol
. 2024 Jun;
31(15):1863-1875.
PMID: 38869144
Aims: Benefits of pharmacologic omega-3 fatty acid administration in cardiovascular prevention are controversial. Particularly, effects on coronary revascularization are unclear; also debated are specific benefits of eicosapentaenoic acid (EPA). We...
7.
Baragetti A, Grigore L, Olmastroni E, Mattavelli E, Catapano A
Vascul Pharmacol
. 2024 Jun;
156:107394.
PMID: 38866119
Purpose: Performing non-invasive carotid imaging is challenging, owing inter-operator variability and organizational barriers, but plasma proteomics can offer an alternative. We sought plasma proteins that associate with the presence of...
8.
Cattaneo M, Baragetti A, Malovini A, Ciaglia E, Lopardo V, Olmastroni E, et al.
Immun Ageing
. 2024 Mar;
21(1):19.
PMID: 38468336
Background: Increased levels of pro-inflammatory proteins in plasma can be detected in older individuals and associate with the so called chronic low-grade inflammation, which contributes to a faster progression of...
9.
Mattavelli E, Piperni E, Asnicar F, Redaelli L, Grigore L, Pellegatta F, et al.
Diabetol Metab Syndr
. 2024 Feb;
16(1):50.
PMID: 38409061
Background And Aim: Unhealthy dietary habits and highly caloric foods induce metabolic alterations and promote the development of the inflammatory consequences of obesity, insulin resistance, diabetes and cardiovascular diseases. Describing...
10.
Baragetti A, Norata G
J Cell Immunol
. 2024 Feb;
5(5):168-173.
PMID: 38327649
Metabolic alterations induced by unhealthy lifestyles, including obesity and insulin resistance are often associated with increased innate immune response and chronic inflammation. Cholesterol has been identified as a key metabolite...